Resident T Cell Activation Leads to Human Hair Follicle Immune Privilege Loss Ex Vivo, Which Is Prevented by the DHODH Inhibitor Farudodstat: Relevance for Alopecia Areata

    April 2026 in “ Frontiers in Medicine
    Ilaria Piccini, Thomas Rouillé, Wolfgang Funk, F. J. Jiménez Jiménez, F. J. Jiménez Jiménez, Alexandre Kaoukhov, C. Firth, Amos Gilhar, Janin Edelkamp, Ferda Cevikbas
    Image of study
    TLDR Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.
    This study investigates the role of hair follicle (HF) resident T cells in the immune privilege (IP) collapse associated with alopecia areata (AA). Using a human HF organ culture model, researchers activated resident T cells with αCD3/αCD28 antibodies, leading to increased T cell proliferation and signs of IP collapse, such as elevated MHC class I and II expression. The study further explored the effects of the DHODH inhibitor farudodstat, which, when administered prior to and during T cell activation, reduced T cell proliferation and MHC expression, thereby preventing IP collapse. These findings suggest that T cell activation is crucial in AA pathogenesis and that farudodstat may offer therapeutic potential by mitigating IP collapse.
    Discuss this study in the Community →